EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study

Ilkka Helanterä, Fernanda Ortiz, Essi Havula, Samuli Tuominen, Markus Hakamäki, Tapio Hellman, Satu Mäkelä, Riku Korhonen

Transplant International · 2026

DOI: 10.3389/ti.2026.16893 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplant International, 2026. Verfasst von Ilkka Helanterä und 7 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation and Liver Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections, Leukopenia. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective observational study investigated the frequency of post-transplant leukopenia and neutropenia (PTLN) and its association with cytomegalovirus (CMV) infections, clinical outcomes, and healthcare resource utilization (HCRU) in kidney transplant recipients (KTRs) in Finland. Clinical and HCRU data were collected from electronic medical records and national registries for the years 2013–2022. Clinical outcomes were assessed during the first 18 months, and cost-related outcomes were evaluated up to 4 years post-transplant. The cohort included 966 KTRs, with the following donor/recipient CMV serostatus distribution: R+ 706 (73.1%), D+/R─ 200 (20.7%), and D─/R─ 60 (6.2%). At 12 months, PTLN occurred in 224 (31.7%) R+, 103 (51.5%) D+/R─, and 6 (10.0%) D─/R─ recipients (p < 0.001). Valganciclovir prophylaxis was started in 28.0% of R+ and 95.0% of D+/R─ patients. CMV DNAemia occurred in 357 (50.6%) R+ and 106 (53.0%) D+/R─ recipients, with median time to CMV DNAemia of 66 days (IQI: 48–110) in R+ and 239 days (IQI: 175–323) in D+/R─ recipients (p < 0.001). PTLN and D+/R─ serostatus were associated with higher HCRU and increased healthcare costs. In conclusion, PTLN was more common in CMV D+/R─ KTRs and both D+/R─ serostatus and PTLN were linked to greater healthcare utilization and cost burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCytomegalovirus InfectionsLeukopeniaHumansFinlandRetrospective StudiesFemaleMaleMiddle AgedAdultValganciclovirNeutropeniaAntiviral AgentsTime Factors

Stichwörter der Autor:innen

CMVkidney transplantationleukopenianeutropeniavalganciclovir

Substanzen

ValganciclovirAntiviral Agents

Autor:innen und Institutionen

  • Transplantation and Liver Surgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Helsinki University Hospital, Abdominal Center, Nephrology, Helsinki, Finland.
  • Medaffcon Oy, Espoo, Finland.
  • Kidney Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Zitieren

APA

Helanterä, I., Ortiz, F., Havula, E., Tuominen, S., Hakamäki, M., Hellman, T., Mäkelä, S., & Korhonen, R. (2026). The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study. Transplant International. https://doi.org/10.3389/ti.2026.16893

Vancouver

Helanterä I, Ortiz F, Havula E, Tuominen S, Hakamäki M, Hellman T, et al. The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study. Transplant International. 2026. doi:10.3389/ti.2026.16893

BibTeX
@article{Helanter2026,
  author = {Helanterä, Ilkka and Ortiz, Fernanda and Havula, Essi and Tuominen, Samuli and Hakamäki, Markus and Hellman, Tapio and Mäkelä, Satu and Korhonen, Riku},
  title = {The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study},
  journal = {Transplant International},
  year = {2026},
  doi = {10.3389/ti.2026.16893}
}
Kostenlos starten →